Translating SEPHNELO with Dr. Grace Wright

Join PSN at this event, sponsored by AstraZeneca, live at Cafe Napoli in Clayton, MO on Wednesday May 25th. Dr. Grace Wright, MD, PhD, FACR, President for the Association of Women in Rheumatology, presenting.

If you are unable to attend in person, you may join in virtually by registering for event access at saphnelobroadcast.com.

DOWNLOAD EVENT FLYER

INDICATION
SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. 
Limitations of Use: The efficacy of SAPHNELO has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Use is not recommended in these situations.

Please see Important Safety Information below and full Prescribing Information including Patient Information.